Wang, Angela Yee-Moon <br/><br/>
Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?  [electronic resource] 

 -  Nephrology (Carlton, Vic.)  Aug 2004 
 - 190-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1320-5358 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1797.2004.00260.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Animals<br/>Blood Pressure<br/>Humans<br/>Hypertrophy, Left Ventricular--drug therapy<br/>Kidney Failure, Chronic--complications<br/>Prognosis<br/>Renin-Angiotensin System--physiology<br/>Sympathetic Nervous System--physiopathology